Lewis Asset Management, LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 2004520 LAFAYETTE, CA

Position in NTLA

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$309,128

+$55,677 QoQ

Shares Held

18,270

-7.6% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#186

of 327 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lewis Asset Management, LLC holds $4,040,524 across 4 Biotechnology names. NTLA ranks #3 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	66,790	$2,605,477
2	CRNX	Crinetics Pharmaceuticals, Inc.	24,325	$910,241
3	NTLA	Intellia Therapeutics, Inc. This page	18,270	$309,128
4	DFTX	Definium Therapeutics, Inc.	4,585	$215,678

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$309,128	18,270	-7.6%	Shares	Sole	2026-07-21
2026-03-31	$253,451	19,770	+38.5%	Shares	Sole	2026-04-21
2025-12-31	$128,287	14,270	-41.9%	Shares	Sole	2026-01-15
2025-09-30	$423,805	24,540	-31.5%	Shares	Sole	2025-10-20
2025-06-30	$336,038	35,825	-6.9%	Shares	Sole	2025-07-14
2025-03-31	$273,699	38,495	-6.1%	Shares	Sole	2025-05-05
2024-12-31	$478,001	40,995	-38.2%	Shares	Sole	2025-01-23
2024-09-30	$1,362,629	66,308	+42.5%	Shares	Sole	2024-10-31
2024-06-30	$1,041,408	46,533	+52.1%	Shares	Sole	2024-07-30
2024-03-31	$841,613	30,593	+32.4%	Shares	Sole	2024-05-01
2023-12-31	$704,410	23,103	—	Shares	Sole	2024-01-23
No filing history on record for this holder in this stock.